Xiaolan Lu

645 total citations
33 papers, 469 citations indexed

About

Xiaolan Lu is a scholar working on Epidemiology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xiaolan Lu has authored 33 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Pathology and Forensic Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xiaolan Lu's work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (5 papers) and Alcohol Consumption and Health Effects (5 papers). Xiaolan Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (5 papers) and Alcohol Consumption and Health Effects (5 papers). Xiaolan Lu collaborates with scholars based in China, United States and Canada. Xiaolan Lu's co-authors include Qin Du, Xiaolan Guo, Qiang Wang, Guoyuan Zhang, Bin Guo, Qiang Ma, Fang Li, Bing Zhang, Dongsheng Wang and Guoyuan Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Kidney International.

In The Last Decade

Xiaolan Lu

31 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Lu China 13 140 130 113 74 67 33 469
Zhenwei Yang China 13 81 0.6× 208 1.6× 201 1.8× 23 0.3× 107 1.6× 35 618
Lucilla Crudele Italy 13 198 1.4× 245 1.9× 53 0.5× 35 0.5× 42 0.6× 34 696
Akiko Yoshikawa Japan 13 108 0.8× 148 1.1× 50 0.4× 32 0.4× 62 0.9× 36 433
Rodrigo Benedetti Gassen Brazil 12 99 0.7× 138 1.1× 68 0.6× 14 0.2× 45 0.7× 29 693
Hada C. Macher Spain 13 152 1.1× 133 1.0× 47 0.4× 24 0.3× 149 2.2× 31 567
Yin Ping Wong Malaysia 12 146 1.0× 155 1.2× 24 0.2× 46 0.6× 34 0.5× 57 599
Alberto Nicoletti Italy 10 147 1.1× 194 1.5× 42 0.4× 16 0.2× 45 0.7× 23 408
Tianyou Chen China 12 59 0.4× 160 1.2× 58 0.5× 36 0.5× 44 0.7× 51 451
Nikolaos Papadopoulos Greece 13 359 2.6× 81 0.6× 53 0.5× 36 0.5× 53 0.8× 45 618
Tsutomu Tamai Japan 14 269 1.9× 98 0.8× 18 0.2× 61 0.8× 32 0.5× 37 508

Countries citing papers authored by Xiaolan Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lu more than expected).

Fields of papers citing papers by Xiaolan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lu. The network helps show where Xiaolan Lu may publish in the future.

Co-authorship network of co-authors of Xiaolan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Lu. A scholar is included among the top collaborators of Xiaolan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Lu. Xiaolan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Hao, et al.. (2025). A novel method for detecting SARS-CoV-2 IgM and IgG based on the gold immune chromatography assay. Scientific Reports. 15(1). 4995–4995. 1 indexed citations
2.
Wang, Yatao, et al.. (2023). Deletion of the PPARδ gene exacerbates high-fat diet-induced nonalcoholic fatty liver disease in mice through the gut-liver axis. Cellular and Molecular Biology. 69(10). 121–128. 3 indexed citations
3.
Shi, Ameng, Jiang Deng, Juan Ma, et al.. (2023). Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults. Obesity Facts. 16(6). 548–558. 3 indexed citations
4.
Wang, Qiang, et al.. (2023). Nomogram to determine predictive risk for active tuberculosis based on the QuantiFERON-TB Gold In-Tube test. Scientific Reports. 13(1). 11963–11963.
5.
Chen, Zhiqiang, Hanyuan Liu, Hongfei Zhu, et al.. (2023). From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era. Biomedicine & Pharmacotherapy. 158. 114208–114208. 17 indexed citations
6.
Lu, Xiaolan, Wen Liu, Nan Sheng, et al.. (2021). A method to alleviate false-positive results of the Elecsys HIV combi PT assay. Scientific Reports. 11(1). 1033–1033. 3 indexed citations
7.
8.
Wang, Qiang, et al.. (2020). Mechanism of heparin interference in detection of LIAISON® Rubella IgM. Clinica Chimica Acta. 511. 7–13. 1 indexed citations
9.
10.
Wang, Qiang, Lei Yan, Xiaolan Lu, et al.. (2019). Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA. PLoS ONE. 14(3). e0212893–e0212893. 18 indexed citations
11.
Guo, Xiaoyang, Xin Shi, Xiaoyu Kang, et al.. (2019). Risk Factors Associated with Inadequate Bowel Preparation in Patients with Functional Constipation. Digestive Diseases and Sciences. 65(4). 1082–1091. 19 indexed citations
12.
Li, Xue, Xiaolan Lu, Juntao He, et al.. (2018). Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model. Pathology - Research and Practice. 214(11). 1778–1786. 3 indexed citations
13.
Tang, Zhiming, et al.. (2017). Expression of TGF-β1/mTOR signaling pathway in pathological scar fibroblasts. Molecular Medicine Reports. 15(6). 3467–3472. 20 indexed citations
14.
Liu, Wenjuan, Xiaolan Lu, Qinghua Wang, et al.. (2016). Exogenous kallikrein protects against diabetic nephropathy. Kidney International. 90(5). 1023–1036. 31 indexed citations
15.
Geng, Yan, Xiangling Wang, Xiaolan Lu, et al.. (2016). Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy. Medicine. 95(5). e2657–e2657. 5 indexed citations
16.
Ding, Yuanyuan, Jingmei Li, Fengjie Guo, et al.. (2016). Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy. Frontiers in Pharmacology. 7. 471–471. 26 indexed citations
17.
Lu, Xiaolan, et al.. (2015). [Epidemiological investigation of fatty liver disease in Northwest China].. PubMed. 23(8). 622–7. 4 indexed citations
18.
Liu, Huan, Erli Yang, Xiaolan Lu, et al.. (2015). Serum levels of tumor necrosis factor-related apoptosis-inducing ligand correlate with the severity of pulmonary hypertension. Pulmonary Pharmacology & Therapeutics. 33. 39–46. 17 indexed citations
19.
Shi, Haitao, Yaping Liu, Jia Miao, et al.. (2013). [Effect of high glucose on toll-like receptor 4 expression and LPS-induced proinflammatory cytokine production in hepatic stellate cells in vitro].. PubMed. 33(3). 386–90. 2 indexed citations
20.
Lu, Xiaolan. (2004). Risk factors for alcoholic liver disease in China. World Journal of Gastroenterology. 10(16). 2423–2423. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenwei Yang Breakdown of academic impact, for papers by Lucilla Crudele Breakdown of academic impact, for papers by Akiko Yoshikawa Breakdown of academic impact, for papers by Rodrigo Benedetti Gassen Breakdown of academic impact, for papers by Hada C. Macher Breakdown of academic impact, for papers by Yin Ping Wong Breakdown of academic impact, for papers by Alberto Nicoletti Breakdown of academic impact, for papers by Tianyou Chen Breakdown of academic impact, for papers by Nikolaos Papadopoulos Breakdown of academic impact, for papers by Tsutomu Tamai
Rankless by CCL
2026